Kurt Mussina, General Manager of Frenova Renal Research and Vice President of Clinical Studies Operations for Fresenius Medical Care North America, recently discussed the barriers to enrolling renal patients in clinical trials that are investigating potential new pharmaceuticals and medical devices.
